BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 9, 2006
View Archived Issues
Inspire Terminating Phase II Trial Of INS50589 Antiplatelet
Inspire Pharmaceuticals Inc. may have hit the end of the road for a Phase II product designed for use in cardiopulmonary bypass procedures. (BioWorld Today)
Read More
Neurocrine, Valentis Dropping Staff In Wake Of Drug Failures
Read More
After Knocking Out Genes, Rye Grass Pollen Made Sneeze-Free
Read More
Genizon Signs Genentech To Use Crohn's GeneMap
Read More
Other News To Note
Read More
Clinic Roundup
Read More